Literature DB >> 11269681

Outcome of renal transplantation in fibrillary glomerulonephritis.

M Samaniego1, G M Nadasdy, Z Laszik, T Nadasdy.   

Abstract

Fibrillary glomerulonephritis (FGN) is a rare but progressive glomerular disease usually with end-stage renal disease (ESRD) developing within months or few years following the diagnosis. Little is known about the outcome of renal transplantation in patients with ESRD due to FGN. We report four patients with FGN who received renal allografts. Two patients developed recurrent FGN in their grafts. One patient was diagnosed to have recurrent FGN 9 years post-transplant, and lost his graft 4 years thereafter. Another patient had recurrent disease 2 years post-transplant but has stable graft function after 7 years. One patient died with normal renal allograft function 7 years following transplantation. The fourth patient has chronic transplant nephropathy 34 months post-transplant without evidence of recurrent FGN. A literature review revealed 10 additional patients who received 11 renal allografts due to ESRD caused by FGN. Four of these 10 patients had biopsy-proven recurrence (one patient in two subsequent grafts), but this caused graft loss only in 2 patients 56 months and 7 years post-transplant, respectively. The earliest recurrence was diagnosed 2 years post-transplant. We conclude that although the recurrence rate of FGN in renal transplants is high (around 50%), the recurrent disease has a relatively benign course and prolonged graft survival is possible.

Entities:  

Mesh:

Year:  2001        PMID: 11269681

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

1.  Treatment of fibrillary glomerulonephritis by corticosteroids and tripterygium glycoside tablets: A case report.

Authors:  Zhao-Yu Lu; Hai-Feng Yang; Yu Peng; Yin Li; Zi-Chang Yin; Fu-Hua Lu; Xu-Sheng Liu
Journal:  Chin J Integr Med       Date:  2016-03-29       Impact factor: 1.978

Review 2.  Fibrillary Glomerulonephritis and DnaJ Homolog Subfamily B Member 9 (DNAJB9).

Authors:  Nattawat Klomjit; Mariam Priya Alexander; Ladan Zand
Journal:  Kidney360       Date:  2020-07-08

3.  Histologic regression of fibrillary glomerulonephritis: the first report of biopsy-proven spontaneous resolution of disease.

Authors:  Miroslav Sekulic; Samih H Nasr; Joseph P Grande; Lynn D Cornell
Journal:  Clin Kidney J       Date:  2017-06-05

Review 4.  Recurrent and de novo Glomerulonephritis After Kidney Transplantation.

Authors:  Wai H Lim; Meena Shingde; Germaine Wong
Journal:  Front Immunol       Date:  2019-08-14       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.